TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Janssons Immunbiologiska AB JIBA
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 6,230 | 6,180 | 6,550 |
Financial expenses | 3 | 7 | 7 |
Earnings before taxes | 1,196 | 1,199 | 2,055 |
EBITDA | 1,195 | 1,205 | 2,067 |
Total assets | 3,283 | 3,292 | 2,580 |
Current assets | 3,283 | 3,292 | 2,580 |
Current liabilities | 559 | 602 | 824 |
Equity capital | 2,724 | 2,690 | 1,750 |
- share capital | 100 | 100 | 100 |
Employees (average) | 2 | 2 | 5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 83.0% | 81.7% | 67.8% |
Turnover per employee | 3,115 | 3,090 | 1,310 |
Profit as a percentage of turnover | 19.2% | 19.4% | 31.4% |
Return on assets (ROA) | 36.5% | 36.6% | 79.9% |
Current ratio | 587.3% | 546.8% | 313.1% |
Return on equity (ROE) | 43.9% | 44.6% | 117.4% |
Change turnover | 50 | -370 | -561 |
Change turnover % | 1% | -6% | -8% |
Chg. No. of employees | 0 | -3 | 0 |
Chg. No. of employees % | 0% | -60% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.